Page last updated: 2024-08-24

tallimustine and Neutropenia

tallimustine has been researched along with Neutropenia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cavalli, F; de Jong, J; Hofmann, C; Lassus, M; Marrari, P; Pagani, O; Sessa, C; Strolin Benedetti, M; Zurlo, MG	1
Ayoub, J; Cormier, Y; DiPietro, N; Shepherd, F; Steward, W; Stewart, D; Viallet, J	1
Bisiach, M; D'Incalci, M; Filippini, C; Tagliabue, G; Ubezio, P	1

Trials

2 trial(s) available for tallimustine and Neutropenia

Article	Year
Phase I study of the novel distamycin derivative tallimustine (FCE 24517). Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Distamycins; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Nitrogen Mustard Compounds; Remission Induction	1994
Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group. Lung cancer (Amsterdam, Netherlands), 1996, Volume: 15, Issue:3 Topics: Aged; Antineoplastic Agents; Canada; Carcinoma, Small Cell; Disease Progression; Distamycins; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Nitrogen Mustard Compounds	1996

Article

Year

Phase I study of the novel distamycin derivative tallimustine (FCE 24517).

Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:10

Topics: Adult; Aged; Antineoplastic Agents; Distamycins; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Nitrogen Mustard Compounds; Remission Induction

1994

Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group.

Lung cancer (Amsterdam, Netherlands), 1996, Volume: 15, Issue:3

Topics: Aged; Antineoplastic Agents; Canada; Carcinoma, Small Cell; Disease Progression; Distamycins; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Nitrogen Mustard Compounds

1996

Other Studies

1 other study(ies) available for tallimustine and Neutropenia

Article	Year
Hematopoietic toxicity and cell cycle perturbations induced by new DNA minor groove-alkylating agents. International journal of cancer, 1997, Sep-04, Volume: 72, Issue:5 Topics: Animals; Antineoplastic Agents, Alkylating; Benzofurans; Body Weight; Bone Marrow Cells; Cell Cycle; Cell Division; Distamycins; Duocarmycins; Flow Cytometry; Indoles; Leukocyte Count; Male; Melphalan; Mice; Mice, Inbred Strains; Neutropenia; Nitrogen Mustard Compounds; Survival Rate; Thrombocytopenia	1997

Article

Year

Hematopoietic toxicity and cell cycle perturbations induced by new DNA minor groove-alkylating agents.

International journal of cancer, 1997, Sep-04, Volume: 72, Issue:5

Topics: Animals; Antineoplastic Agents, Alkylating; Benzofurans; Body Weight; Bone Marrow Cells; Cell Cycle; Cell Division; Distamycins; Duocarmycins; Flow Cytometry; Indoles; Leukocyte Count; Male; Melphalan; Mice; Mice, Inbred Strains; Neutropenia; Nitrogen Mustard Compounds; Survival Rate; Thrombocytopenia

1997